Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders
Authors:
- P. ManoharanPMP. Manoharan
- S. JamiesonSJS. Jamieson
- R.F. BuryRBR.F. Bury
- 1 May 2007
- journal article
- case report
- Published by Elsevier in Clinical Radiology
- Vol. 62 (5) , 463-471
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- How useful is [123I] -CIT SPECT in clinical practice?Journal of Neurology, Neurosurgery & Psychiatry, 2005
- Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromesMovement Disorders, 2004
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002
- Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study groupMovement Disorders, 2000
- Accuracy of diagnosis in patients with presumed Parkinson's diseaseAge and Ageing, 1999
- [ 11 C]raclopride and positron emission tomography in previously untreated patients with Parkinson's diseaseNeurology, 1994